Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Chiara Parati

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Tumori|September 27, 2022
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic reviewAndrea Luciani, Antonio Ghidini, Karen Borgonovo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2021
Adjuvant chemotherapy for pT1abN0M0 triple-negative breast cancer: a systematic review and meta-analysis of published studiesFausto Petrelli, Maria Chiara Parati, Karen Borgonovo, et al.
Thrombosis Research|January 10, 2022
Osimertinib-related venous thromboembolism in non small lung cancerFausto Petrelli, Mary Cabiddu, Karen Borgonovo, et al.
Journal of Geriatric Oncology|December 11, 2025
Safety of CDK4/6 inhibitors in older patients: A FAERS-based analysis of serious and fatal adverse eventsFausto Petrelli, Alessandro Iaculli, Maria Chiara Parati, et al.
Cancers|November 26, 2022
COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-AnalysisSimone Oldani, Fausto Petrelli, Giuseppina Dognini, et al.
Journal of Medical Virology|February 4, 2022
Third dose of SARS-CoV-2 vaccine: A systematic review of 30 published studiesFausto Petrelli, Andrea Luciani, Karen Borgonovo, et al.
Breast (Edinburgh, Scotland)|May 17, 2023
The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysisFausto Petrelli, Lorenzo Dottorini, Giandomenico Di Menna, et al.
Breast Cancer Research and Treatment|January 20, 2019
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trialsFausto Petrelli, Antonio Ghidini, Rebecca Pedersini, et al.
Clinical Nutrition ESPEN|August 23, 2024
Vitamin D3 and cancer risk in healthy subjects: An umbrella review of systematic review and meta-analysisFausto Petrelli, Rita Deda, Karen Borgonovo, et al.
Breast Cancer (Dove Medical Press)|April 20, 2022
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients SelectionMaria Chiara Parati, Rebecca Pedersini, Gianluca Perego, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Tumori|September 27, 2022
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic reviewAndrea Luciani, Antonio Ghidini, Karen Borgonovo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2021
Adjuvant chemotherapy for pT1abN0M0 triple-negative breast cancer: a systematic review and meta-analysis of published studiesFausto Petrelli, Maria Chiara Parati, Karen Borgonovo, et al.
Thrombosis Research|January 10, 2022
Osimertinib-related venous thromboembolism in non small lung cancerFausto Petrelli, Mary Cabiddu, Karen Borgonovo, et al.
Journal of Geriatric Oncology|December 11, 2025
Safety of CDK4/6 inhibitors in older patients: A FAERS-based analysis of serious and fatal adverse eventsFausto Petrelli, Alessandro Iaculli, Maria Chiara Parati, et al.
Cancers|November 26, 2022
COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-AnalysisSimone Oldani, Fausto Petrelli, Giuseppina Dognini, et al.
Journal of Medical Virology|February 4, 2022
Third dose of SARS-CoV-2 vaccine: A systematic review of 30 published studiesFausto Petrelli, Andrea Luciani, Karen Borgonovo, et al.
Breast (Edinburgh, Scotland)|May 17, 2023
The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysisFausto Petrelli, Lorenzo Dottorini, Giandomenico Di Menna, et al.
Breast Cancer Research and Treatment|January 20, 2019
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trialsFausto Petrelli, Antonio Ghidini, Rebecca Pedersini, et al.
Clinical Nutrition ESPEN|August 23, 2024
Vitamin D3 and cancer risk in healthy subjects: An umbrella review of systematic review and meta-analysisFausto Petrelli, Rita Deda, Karen Borgonovo, et al.
Breast Cancer (Dove Medical Press)|April 20, 2022
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients SelectionMaria Chiara Parati, Rebecca Pedersini, Gianluca Perego, et al.
Pageof 3